3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Hyperthermia
9
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Sarcoma
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Salivary Gland Adenoma, Pleomorphic
1
Recurrence
1
Rectal Neoplasms
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Pelvic Pain
1
Obesity
1
Neoplasms, Radiation-Induced
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Locally Advanced Rectal Cancer
1
Liver Neoplasms
1
Kidney Neoplasms
1
Cholangiocarcinoma
1
Agnosia
1
Acute Pain
1
Interventions
Metformin
52
Inositol
22
Clomiphene
17
Letrozole
16
Exercise
14
High-Intensity Interval Training
10
Folic Acid
10
Caloric Restriction
10
Progesterone
8
Ethinyl Estradiol
8
Estradiol
7
Diet
6
drospirenone
5
drospirenone and ethinyl estradiol combination
4
Tablets
4
In Vitro Oocyte Maturation Techniques
4
Estrogens
4
Diet, Mediterranean
4
Cyproterone Acetate
4
Control Groups
4
Berberine
4
Acupuncture Therapy
4
Vitamin D
3
Triptorelin Pamoate
3
Thioctic Acid
3
Spironolactone
3
Resistance Training
3
Pioglitazone
3
Medroxyprogesterone Acetate
3
Lactalbumin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Polycystic Ovary Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled